Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
131.06
+0.35 (0.27%)
At close: May 8, 2026, 4:00 PM EDT
130.50
-0.56 (-0.43%)
After-hours: May 8, 2026, 7:56 PM EDT
Celcuity Employees
Celcuity had 155 employees as of December 31, 2025. The number of employees increased by 68 or 78.16% compared to the previous year.
Employees
155
Change (1Y)
68
Growth (1Y)
78.16%
Revenue / Employee
n/a
Profits / Employee
-$1,142,206
Market Cap
6.34B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 155 | 68 | 78.16% |
| Dec 31, 2024 | 87 | 32 | 58.18% |
| Dec 31, 2023 | 55 | 10 | 22.22% |
| Dec 31, 2022 | 45 | 6 | 15.38% |
| Dec 31, 2021 | 39 | 9 | 30.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Mirum Pharmaceuticals | 372 |
| Apogee Therapeutics | 261 |
| Cogent Biosciences | 258 |
| Kymera Therapeutics | 253 |
| CG Oncology | 142 |
| Protagonist Therapeutics | 132 |
CELC News
- 2 days ago - Celcuity Schedules Release of First Quarter 2026 Financial Results and Webcast/Conference Call - GlobeNewsWire
- 5 days ago - Celcuity rises 18.4% - TheFly
- 5 days ago - Celcuity rises 17.1% - TheFly
- 5 days ago - Celcuity price target raised to $189 from $141 at Craig-Hallum - TheFly
- 5 days ago - Celcuity price target raised to $165 from $135 at Guggenheim - TheFly
- 5 days ago - Celcuity price target raised to $157 from $122 at Needham - TheFly
- 5 days ago - Celcuity price target raised to $150 from $125 at Stifel - TheFly
- 5 days ago - Celcuity upgraded to Buy from Neutral at H.C. Wainwright - TheFly